BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27014971)

  • 1. Development and validation of a surgical-pathologic staging and scoring system for cervical cancer.
    Li S; Li X; Zhang Y; Zhou H; Tang F; Jia Y; Hu T; Sun H; Yang R; Chen Y; Cheng X; Lv W; Wu L; Zhou J; Wang S; Huang K; Wang L; Yao Y; Yang Q; Yang X; Zhang Q; Han X; Lin Z; Xing H; Qu P; Cai H; Song X; Tian X; Shen J; Xi L; Li K; Deng D; Wang H; Wang C; Wu M; Zhu T; Chen G; Gao Q; Wang S; Hu J; Kong B; Xie X; Ma D
    Oncotarget; 2016 Apr; 7(15):21054-63. PubMed ID: 27014971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study.
    Kim HS; Choi CH; Lim MC; Chang SJ; Kim YB; Kim MA; Kim TJ; Park SY; Kim BG; Song YS; Bae DS; Kim JW
    Ann Surg Oncol; 2012 Jun; 19(6):1973-9. PubMed ID: 22183162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.
    Pol FJ; Zusterzeel PL; van Ham MA; Kuijpers DA; Bulten J; Massuger LF
    Gynecol Oncol; 2015 Sep; 138(3):579-84. PubMed ID: 26126782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trend in proportion and clinicopathological characteristics of young women with stage Ⅰa2 to Ⅱa2 cervical cancer].
    Wang W; Hao M; Chen CL; Liu P; Ling B; Kang S; Lu AW; Wang WL; Zhao WD; Zhu QY; Zhao YY; Zhao HW; Jin SL; Ni Y; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):666-672. PubMed ID: 31648442
    [No Abstract]   [Full Text] [Related]  

  • 5. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy.
    Metindir J; Bilir G
    Eur J Gynaecol Oncol; 2007; 28(1):28-32. PubMed ID: 17375702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Lymph Node Metastasis and Risk Factors in 975 Patients with FIGO 2009 Stage IA-IIA Cervical Cancer.
    Cao L; Kong W; Li J; Song D; Jin B; Liu T; Han C
    Gynecol Obstet Invest; 2023; 88(1):30-36. PubMed ID: 36450266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
    Kornovski Y; Gorchev G
    J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.
    Chen XL; Chen GW; Xu GH; Ren J; Li ZL; Pu H; Li H
    Int J Gynecol Cancer; 2018 Oct; 28(8):1545-1552. PubMed ID: 30044321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
    Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
    Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis.
    Sevin BU; Lu Y; Bloch DA; Nadji M; Koechli OR; Averette HE
    Cancer; 1996 Oct; 78(7):1438-46. PubMed ID: 8839549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
    Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
    Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential for less radical surgery in women with stage IA2-IB1 cervical cancer.
    Bai H; Yuan F; Wang H; Chen J; Cui Q; Shen K
    Int J Gynaecol Obstet; 2015 Sep; 130(3):235-40. PubMed ID: 26070225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
    Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
    Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
    Ho CM; Chien TY; Huang SH; Wu CJ; Shih BY; Chang SC
    Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between prognostic factors and disease-free survival of cervical cancer stage IB1 patients undergoing radical hysterectomy.
    Chittithaworn S; Hanprasertpong J; Tungsinmunkong K; Geater A
    Asian Pac J Cancer Prev; 2007; 8(4):530-4. PubMed ID: 18260723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.